Proprietary AI analyst is now available
- Public Comps
- China Pacific Insurance
China Pacific Insurance Valuation Multiples
Discover China Pacific Insurance's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Daiichi Life Group, People's Insurance Co, MS&AD Insurance Group, Power Corporation of Canada and more.
China Pacific Insurance Overview
About China Pacific Insurance
Established in 1988, China Pacific Insurance is China's third-largest life insurer and third-largest general property and casualty insurer, with headquarters in Beijing. The company strives to create an integrated financial services platform that encompasses insurance, banking, and asset management. CPIC's major shareholders are state-owned companies related to the Shanghai government.
Founded
1991
HQ

Employees
95.0K
Website
Sectors
Financials (LTM)
EV
$31B
Valuation Multiples
Start free trialChina Pacific Insurance Financials
China Pacific Insurance reported last 12-month revenue of $65B and EBITDA of $8B.
In the same LTM period, China Pacific Insurance generated $8B in EBITDA and $8B in net income.
Revenue (LTM)
China Pacific Insurance P&L
In the most recent fiscal year, China Pacific Insurance reported revenue of $64B and EBITDA of $8B.
China Pacific Insurance is profitable as of last fiscal year, with EBITDA margin of 12% and net margin of 12%.
Financial data powered by Morningstar, Inc.
China Pacific Insurance Stock Performance
China Pacific Insurance has current market cap of $40B, and enterprise value of $31B.
Market Cap Evolution
China Pacific Insurance's stock price is $4.20.
China Pacific Insurance share price decreased by 7.4% in the last 30 days, and by 14.3% in the last year.
China Pacific Insurance has an EPS (earnings per share) of $0.82.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $31B | $40B | 0.0% | -7.4% | -17.0% | -14.3% | $0.82 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChina Pacific Insurance Valuation Multiples
China Pacific Insurance trades at 0.5x EV/Revenue multiple, and 3.7x EV/EBITDA.
EV / Revenue (LTM)
China Pacific Insurance Financial Valuation Multiples
As of June 21, 2026, China Pacific Insurance has market cap of $40B and EV of $31B.
China Pacific Insurance has a P/E ratio of 5.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified China Pacific Insurance Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


China Pacific Insurance Margins & Growth Rates
China Pacific Insurance grew revenue by 5% and EBITDA by 19% in the last fiscal year.
In the most recent fiscal year, China Pacific Insurance reported EBITDA margin of 12% and net margin of 12%.
China Pacific Insurance Margins
China Pacific Insurance Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
China Pacific Insurance Operational KPIs
China Pacific Insurance's revenue per employee in the last FY averaged $0.7M.
China Pacific Insurance's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
China Pacific Insurance's Rule of X is 27% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
China Pacific Insurance Competitors
China Pacific Insurance competitors include Daiichi Life Group, People's Insurance Co, MS&AD Insurance Group, Power Corporation of Canada, AIG, PICC Property & Casualty, Sun Life, Humana Inc., Prudential and The Hartford.
Most China Pacific Insurance public comparables operate across Insurance Carriers.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.5x | 0.5x | 9.4x | 9.3x | |||
| 0.4x | 0.4x | - | - | |||
| 0.9x | 0.7x | - | 5.9x | |||
| 1.9x | 3.6x | - | - | |||
| 1.7x | 1.7x | 11.2x | 9.4x | |||
| 0.6x | 0.6x | 5.3x | 5.2x | |||
| 1.6x | 5.4x | 10.9x | 10.8x | |||
| 0.4x | 0.4x | 12.9x | 15.1x | |||
This data is available for Pro users. Sign up to see all China Pacific Insurance competitors and their valuation data. Start Free Trial | ||||||
Investments by China Pacific Insurance
China Pacific Insurance has invested in 11 companies to date.
Latest investment by China Pacific Insurance was on May 8th 2024. China Pacific Insurance invested in Taiyi Guanjia in their $127M Seed round (EV/Revenue multiple available to Pro users).
Latest Investments by China Pacific Insurance
| Description | - | Bang Er Orthopedic is a specialized hospital operator in China's Yangtze River Delta region. Zhejiang Boner Medical Investment Management Co., Ltd. oversees its network of facilities focused on orthopedics and rehabilitation services. The chain provides advanced treatments for bone injuries, joint disorders, and post-surgical recovery, serving patients in Shanghai, Hangzhou, and surrounding areas. | Tripod Preclinical Research Laboratories is a contract research organization offering GLP-compliant nonclinical safety evaluation services. Taoyuan, Taiwan-based, it conducts toxicology studies, pharmacokinetics, and pathology assessments for new chemical entities, biologics, pesticides, veterinary drugs, and cosmetics targeting global pharmaceutical and biotech clients. | Safe Medical Evaluation is a Beijing-based institute for drug safety testing. Beijing Saifu Medical Research Institute Co., Ltd. partners with the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and Beijing's National Drug Safety Evaluation and Research Center. Its team, drawn from the Academy of Military Medical Sciences, specializes in GLP-compliant toxicology and drug development platforms. | |
| HQ Country | |||||
| HQ City | - | Hangzhou | Nanjing | Beijing | |
| Deal Date | 8 May 2024 | 9 Nov 2023 | 12 Apr 2023 | 2 Dec 2022 | |
| Round | Seed | Series E | Series C | Series D | |
| Raised | $127M | $111M | $6M | $72M | |
| Investors | Mitsui Sumitomo Insurance Company; China Pacific Insurance; HSG; Shanghai International Asset Management | Lake Bleu Capital; Sunshine Insurance Group; October Capital; C&D Emerging Investment; China Pacific Insurance; Gaoyuan Capital | GL Ventures LLC; Hillhouse Ventures; Highlight Capital; Xiaochi Capital; Shanghai Lingang Economic Development; Howbuy; HJ-Investment; Legend Capital; China Pacific Insurance | Taiping Medical and Health Fund; China State-Owned Capital Venture Investment Fund; FOF Capital; Lite Medical Fund; CICC; Jianxing Medical Fund; China Pacific Insurance; SDIC Venture Capital | |
| Valuation | undisclosed | $700M | undisclosed | $574M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all China Pacific Insurance investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout China Pacific Insurance
| When was China Pacific Insurance founded? | China Pacific Insurance was founded in 1991. |
| Where is China Pacific Insurance headquartered? | China Pacific Insurance is headquartered in China. |
| How many employees does China Pacific Insurance have? | As of today, China Pacific Insurance has over 95K employees. |
| Is China Pacific Insurance publicly listed? | Yes, China Pacific Insurance is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of China Pacific Insurance? | China Pacific Insurance trades under 601601 ticker. |
| When did China Pacific Insurance go public? | China Pacific Insurance went public in 2007. |
| Who are competitors of China Pacific Insurance? | China Pacific Insurance main competitors include Daiichi Life Group, People's Insurance Co, MS&AD Insurance Group, Power Corporation of Canada, AIG, PICC Property & Casualty, Sun Life, Humana Inc., Prudential, The Hartford. |
| What is the current market cap of China Pacific Insurance? | China Pacific Insurance's current market cap is $40B. |
| What is the current revenue of China Pacific Insurance? | China Pacific Insurance's last 12 months revenue is $65B. |
| What is the current revenue growth of China Pacific Insurance? | China Pacific Insurance revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of China Pacific Insurance? | Current revenue multiple of China Pacific Insurance is 0.5x. |
| What is the current EBITDA of China Pacific Insurance? | China Pacific Insurance's last 12 months EBITDA is $8B. |
| What is China Pacific Insurance's EBITDA margin? | China Pacific Insurance's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of China Pacific Insurance? | Current EBITDA multiple of China Pacific Insurance is 3.7x. |
| How many companies China Pacific Insurance has acquired to date? | China Pacific Insurance hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies China Pacific Insurance has invested to date? | As of June 2026, China Pacific Insurance has invested in 11 companies. |
| What was the last China Pacific Insurance investment? | On 8th May 2024 China Pacific Insurance invested in Taiyi Guanjia, participating in a $127M Seed round, alongside Mitsui Sumitomo Insurance Company, HSG, and Shanghai International Asset Management. |
See public comps similar to China Pacific Insurance
Lists including China Pacific Insurance
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
